Halamid Aqua (Chloramine-T) Approved by FDA to Treat Fish Diseases
Axcentive SARL announced yesterday that the U.S. Food and Drug Administration (FDA) Center has approved Halamid® Aqua (100% chloramine-T) as a new therapeutic drug for use in fish. Halamid® Aqua is an important weapon in the arsenal fisheries professionals use to combat fish diseases, and its approval is a major advance in fish health management. Halamid® Aqua is only the second waterborne drug approved to treat fish diseases in nearly 30 years. This approval is a huge milestone for those involved in fish culture and fish health, as well as for the public and private-sector partners responsible for getting Halamid® Aqua across the finish line. Our thanks to Axcentive SARL, Association of Fish and Wildlife Agencies , U.S. Fish and Wildlife Service Aquatic Animal Drug Approval Partnership Program, U.S. Geological Survey Upper Midwest Environmental Sciences Center, and the National Aquaculture New Animal Drugs Applications Coordinator!
HALAMID® Aqua can be used to control mortality in:
- Freshwater-reared salmonids due to bacterial gill disease at a dosage of 12—20 mg chloramine-T/L administered for 60 min daily in a static or flow through bath on three consecutive or alternate days,
- Walleye and all freshwater-reared warm water finfish due to external columnaris disease at a dosage of 20 mg chloramine-T/L administered for 60 min daily in a static or flow through bath on three consecutive or alternate days.
For more information and to view the full-length press release, visit the American Fisheries Society Fish Culture Section.